Previous 10 | Next 10 |
2024-06-23 11:13:33 ET Summary Since the publication of my last article, Pfizer has continued to surprise me pleasantly. In early May, Pfizer published financial results for the first quarter of 2024, which were enthusiastically received by Wall Street. On June 14, 2024, the c...
2024-06-22 09:30:00 ET Summary We go over the importance of a DGI portfolio for income investors and retirees. We outline a simple process of selecting 15-20 individual dividend stocks for long-term growth, income, and lower volatility. In the end, we present a 15-stock DGI po...
2024-06-22 08:05:00 ET Summary FOMO is driving stock market decisions, especially with meme stocks like GameStop and high-flying AI stocks. That's why I prefer discounted dividend stocks over growth stocks, and highlight two picks that offer durable capital returns. Both names...
2024-06-22 04:45:00 ET When you invest for the long term, a good strategy is to add stocks from various industries with different growth qualities that complement each other. Dividend stocks generate one type of growth and can be a fantastic way to maximize your returns. They perform differ...
2024-06-21 07:47:27 ET More on Johnson & Johnson Johnson & Johnson (JNJ) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript) Johnson & Johnson: Market Will Regret The Overreaction Johnson & Johnson (JNJ) Bernstein's 40th Annual Strateg...
Acquisition includes two pre-clinical bispecific antibodies targeting proven disease pathways, offering the potential to transform the treatment paradigm for patients living with atopic dermatitis and other immune-mediated diseases Johnson & Johnson (NYSE: JNJ) announced today that ...
2024-06-20 17:11:21 ET More on Johnson & Johnson Johnson & Johnson (JNJ) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript) Johnson & Johnson: Market Will Regret The Overreaction Johnson & Johnson (JNJ) Bernstein's 40th Annual Strateg...
2024-06-20 17:01:11 ET USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – June 20,2024 – USA News Group News Commentary – The potential threat of cancer looms for everyone, but now new studies are revealing an increased number o...
Johnson & Johnson submits application to U.S. FDA seeking approval of TREMFYA® (guselkumab) for the treatment of moderately to severely active Crohn's disease Johnson & Johnson submits application to U.S. FDA seeking approval of TREMFYA® (guselkumab) for the treatment ...
VANCOUVER – USA News Group News Commentary – The potential threat of cancer looms for everyone, but now new studies are revealing an increased number of cancer cases in younger age groups than before. While researchers continue to search for a reason why this is happening, s...
News, Short Squeeze, Breakout and More Instantly...
CARVYKTI® (ciltacabtagene autoleucel) achieved statistically significant and clinically meaningful improvement in overall survival in landmark CARTITUDE-4 study PR Newswire CARVYKTI ® is the first and only BCMA-targeted CAR-T cell therapy approved by the U.S....
2024-07-01 06:50:00 ET Most retirees prefer low turnover in their investment portfolios. The less drama, the better. That way, they can focus on doing what they enjoy instead of worrying about their investments. Three Motley Fool contributors think they've found magnificent stocks retir...
2024-06-29 08:21:00 ET We have closed the books on a strong first half of the year for the U.S. stock market, something that a lot of people overlooked. Now we embark on the second half of the year, which could bring some challenges, though July historically is the market's best-performing ...